Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins

Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins

US Patent 11479613 · Granted Oct 25, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigen-binding domain2025
Antigen-binding domain2025
Engineered cytolytic immunecell2025
Engineered cytolytic immunecell2025
Engineered cytolytic immunecell2025
Engineered cytolytic immunecell2025
Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen recept2025
Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen recept2025
Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen recept2025
Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen recept2025
Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface2025
Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface2025